1. Home
  2. SYPR vs ELOX Comparison

SYPR vs ELOX Comparison

Compare SYPR & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$1.81

Market Cap

47.4M

Sector

Industrials

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$15.22

Market Cap

41.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SYPR
ELOX
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
41.0M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
SYPR
ELOX
Price
$1.81
$15.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.8K
38.2K
Earning Date
05-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.67
EPS
N/A
N/A
Revenue
$82,294,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$10.00
52 Week High
$4.74
$23.40

Technical Indicators

Market Signals
Indicator
SYPR
ELOX
Relative Strength Index (RSI) 45.98 46.90
Support Level $1.79 $10.74
Resistance Level $2.09 $19.66
Average True Range (ATR) 0.10 2.72
MACD 0.02 -0.54
Stochastic Oscillator 56.25 17.83

Price Performance

Historical Comparison
SYPR
ELOX

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc provides products and engineering, design, and manufacturing services for a variety of critical infrastructure sectors, including energy, space, communications, defense, transport, chemical, and water. The company operates in two segments, Sypris Technologies and Sypris Electronics. Sypris Technologies segment includes the sale of forged, machined, welded and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications, whereas the Sypris Electronics segment includes revenue from circuit card and box build manufacturing, high reliability manufacturing and systems assembly and integration, for aerospace and defense, communications and space applications. The majority of revenue is derived from the Sypris Electronics segment.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: